ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
0.3650
-0.0150 (-3.95%)
At close: Apr 25, 2025, 4:00 PM
0.3614
-0.0036 (-0.99%)
After-hours: Apr 25, 2025, 7:27 PM EDT
ReShape Lifesciences Employees
As of December 31, 2024, ReShape Lifesciences had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees decreased by 13 or -41.94% compared to the previous year.
Employees
18
Change (1Y)
-13
Growth (1Y)
-41.94%
Revenue / Employee
$444,778
Profits / Employee
-$396,111
Market Cap
4.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RSLS News
- 6 days ago - ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology - GlobeNewsWire
- 16 days ago - ReShape Lifesciences Inc. (RSLS) Earnings Highlights and Strategic Business Update Conference (Transcript) - Seeking Alpha
- 17 days ago - ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market - GlobeNewsWire
- 19 days ago - ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS - Business Wire
- 6 weeks ago - ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology - GlobeNewsWire
- 2 months ago - ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX - GlobeNewsWire
- 2 months ago - ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering - GlobeNewsWire